Valid for Submission
D81.31 is a billable diagnosis code used to specify a medical diagnosis of severe combined immunodeficiency due to adenosine deaminase deficiency. The code D81.31 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D81.31 might also be used to specify conditions or terms like scid due to absent adenosine deaminase or scid due to absent lymphoid stem cells.
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D81.31:
Inclusion TermsInclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- ADA deficiency with SCID
- Adenosine deaminase ADA deficiency with severe combined immunodeficiency
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D81.31 are found in the index:
- - Deficiency, deficient
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- SCID due to absent adenosine deaminase
- SCID due to absent lymphoid stem cells
D8131 replaces the following previously assigned ICD-10 code(s):